Infant Bacterial Therapeutics AB is a clinical stage pharmaceutical company, which engages in the development of drugs for the treatment of rare diseases affecting premature infants. The company is headquartered in Stockholm, Stockholm and currently employs 10 full-time employees. The company went IPO on 2016-03-29. The firm develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of necrotizing enterocolitis (NEC), a fatal disease that affects premature infants.
Principales calificaciones de analistas para IFTBF
Basado en 9 analistas que dan calificaciones de acciones a IFTBF, actualizado el Dec 01, 2021
Strong Buy
Strong buy
3
Buy
5
Hold
1
Sell
0
Strong sell
0
Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for IFTBF. Our analysts highlight strong fundamentals and favorable market sentiment, positioning IFTBF for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: IFTBF is a Strong Buy candidate.
IFTBF stock price ended at $5.47 on Jueves, after rising 14.44%
On the latest trading day Jan 08, 2026, the stock price of IFTBF rose by 14.44%, climbing from $5.47 to $5.47. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $5.47 and a high of $5.47. Alongside this price increase, trading volume also rose by 348 shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 852 shares were traded, amounting to a market value of approximately --.
Señales Técnicas de IFTBF
Resumen de Señales Técnicas
Señales de compra 0
Señales Neutras 7
Señales de venta 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
IFTBF actualmente presenta 0 señales de compra y 0 señales de venta. La acción ha estado en una tendencia alcista desde 12:00 AM, con un cambio total en el precio de 14.44% durante este período. En general, los indicadores técnicos apuntan a una perspectiva Neutral para el mediano plazo.
Señales alcistas/bajistas para IFTBF
Analizamos indicadores clave como medias móviles, RSI, MACD y volumen de negociación para generar señales alcistas y bajistas para IFTBF. Estas perspectivas te ayudan a tomar decisiones de inversión más informadas.
Preguntas de seguimiento
¿Cómo se aplican los indicadores de análisis técnico a IFTBF?
¿Cuáles son los niveles de retroceso de Fibonacci para IFTBF?
¿Cuál es el RSI de Infant Bacterial Therapeutics AB (publ)?
¿Cuál es el precio de Infant Bacterial Therapeutics AB (publ) para los próximos 12 meses?
¿Hasta dónde se espera que suba Infant Bacterial Therapeutics AB (publ)?